Literature DB >> 22561557

RETRACTED: MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.

Xue-Mei Xu1, Xiao-Bo Wang, Miao-Miao Chen, Tao Liu, Yi-Xuan Li, Wei-Hua Jia, Min Liu, Xin Li, Hua Tang.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Upon investigation, it was discovered that 4 out of 8 images contain fabrication. Figures 6D, 6E, 8E and 7F have used the same microscopic image for different experimental settings. The Figure represented in 8E is the correct image placement. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561557     DOI: 10.1016/j.canlet.2012.02.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  68 in total

1.  MicroRNA-19a promotes glioma cell growth by repressing LRIG1.

Authors:  Ling-Min Shao; Ji-An Yang; Yue-Fei Wang; Peng Wu; Ji-Qiang Li; Qian-Xue Chen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

3.  The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.

Authors:  Grégoire Stik; Ginette Dambrine; Sébastien Pfeffer; Denis Rasschaert
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

4.  MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition.

Authors:  Xiaomei Wu; Xiaowei Xi; Qin Yan; Zhenbo Zhang; Bin Cai; Wen Lu; Xiaoping Wan
Journal:  Med Oncol       Date:  2013-10-26       Impact factor: 3.064

5.  MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.

Authors:  Jian-Mei Wang; Bao-Hui Ju; Cai-Jun Pan; Yan Gu; Meng-Qi Li; Li Sun; Yan-Ying Xu; Li-Rong Yin
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

6.  MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.

Authors:  Qi-guang Chen; Wei Zhou; Tao Han; Shu-qi Du; Zhen-hua Li; Zhe Zhang; Guang-yi Shan; Chui-ze Kong
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-31       Impact factor: 4.553

7.  MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.

Authors:  Tian-Yi Wu; Tian-Hong Zhang; Ling-Mei Qu; Jia-Peng Feng; Lin-Li Tian; Bing-Hui Zhang; Dan-Dan Li; Ya-Nan Sun; Ming Liu
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

8.  IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.

Authors:  Jie-Mei Wang; Yining Qiu; Zhao Yang; Hyunbae Kim; Qingwen Qian; Qinghua Sun; Chunbin Zhang; Lei Yin; Deyu Fang; Sung Hong Back; Randal J Kaufman; Ling Yang; Kezhong Zhang
Journal:  Sci Signal       Date:  2018-05-15       Impact factor: 8.192

9.  Huaiqihuang may protect from proteinuria by resisting MPC5 podocyte damage via targeting p-ERK/CHOP pathway.

Authors:  Tingxia Li; Jianhua Mao; Lei Huang; Haidong Fu; Shuohui Chen; Aimin Liu; Yuqin Liang
Journal:  Bosn J Basic Med Sci       Date:  2016-05-17       Impact factor: 3.363

Review 10.  The functions and properties of cullin-5, a potential therapeutic target for cancers.

Authors:  Feng Gao; Yimin Fan; Bolun Zhou; Weihua Guo; Xingjun Jiang; Jing Shi; Caiping Ren
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.